This compound is a gadolinium-containing complex used as a reference impurity in the quality control of gadobutrol, an MRI contrast agent. It is supplied as a research-grade chemical for analytical method development and impurity profiling studies.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 112188-16-6
1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid trisodium salt
pharmaceutical intermediate
4,5-Dicyanoimidazole
Pharmaceutical intermediate
4-acetylpyridine
pharmaceutical intermediate
6-Methyl-2-pyridinemethanol
pharmaceutical intermediate
4-Bromobenzaldehyde
pharmaceutical intermediate
Gadoteric acid
pharmaceutical raw material
Gadoterate meglumine
pharmaceutical raw material
Gadoteridol
pharmaceutical raw material
2-[4,7-bis(carboxylatomethyl)-1,4,7,10-tetrazacyclododec-1-yl]acetate;gadolinium(3+)
SGPXHPCSEYUXPA-UHFFFAOYSA-K
C1CN(CCN(CCN(CCN1)CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Gd+3]